ProShares Ultra Nasdaq Biotechnology
BIB
#2853
ETF rank
โ‚ฌ87.93 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
99,93ย โ‚ฌ
Share price
-1.08%
Change (1 day)
50.95%
Change (1 year)

Expense ratio and fees for ProShares Ultra Nasdaq Biotechnology (BIB)

Expense Ratio

Expense Ratio as of November 2026: 0.95%

Gross Expense Ratio

Gross Expense Ratio as of November 2026: 1.17%

Net Expense Ratio

Net Expense Ratio as of November 2026: 0.95%